Compare · head to head
Enovis vs Stryker
Stryker ranks higher overall — 360 rank 60 vs 40.
Enovis leads on Value (56 vs 34) and Sentiment (69 vs 54). Stryker leads on Quality (66 vs 44), Growth (56 vs 41) and Safety (51 vs 28).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| Size | Large | Large |
| ISIN | US1940145022 | US8636671013 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 40 | 60 |
| Value | 56 | 34 |
| Quality | 44 | 66 |
| Growth | 41 | 56 |
| Safety | 28 | 51 |
| Sentiment | 69 | 54 |
| Quality details | ||
| Profitability | 35 | 69 |
| Cash Truth | 54 | 63 |
Enovis vs Sight SciencesEnovis vs SI-BONEEnovis vs Globus MedicalEnovis vs CONMEDAdd a third stock →
Full analyses: Enovis · Stryker
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100